These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

531 related articles for article (PubMed ID: 19416991)

  • 1. Protective effects of sphingosine-1-phosphate receptor agonist treatment after myocardial ischaemia-reperfusion.
    Hofmann U; Burkard N; Vogt C; Thoma A; Frantz S; Ertl G; Ritter O; Bonz A
    Cardiovasc Res; 2009 Jul; 83(2):285-93. PubMed ID: 19416991
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacological pre- and post-conditioning with the sphingosine-1-phosphate receptor modulator FTY720 after myocardial ischaemia-reperfusion.
    Hofmann U; Hu K; Walter F; Burkard N; Ertl G; Bauersachs J; Ritter O; Frantz S; Bonz A
    Br J Pharmacol; 2010 Jul; 160(5):1243-51. PubMed ID: 20590616
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sphingosine 1-phosphate is an important endogenous cardioprotectant released by ischemic pre- and postconditioning.
    Vessey DA; Li L; Honbo N; Karliner JS
    Am J Physiol Heart Circ Physiol; 2009 Oct; 297(4):H1429-35. PubMed ID: 19648253
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sphingosine 1-phosphate S1P2 and S1P3 receptor-mediated Akt activation protects against in vivo myocardial ischemia-reperfusion injury.
    Means CK; Xiao CY; Li Z; Zhang T; Omens JH; Ishii I; Chun J; Brown JH
    Am J Physiol Heart Circ Physiol; 2007 Jun; 292(6):H2944-51. PubMed ID: 17293497
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sphingosine-1-phosphate reduces ischaemia-reperfusion injury by phosphorylating the gap junction protein Connexin43.
    Morel S; Christoffersen C; Axelsen LN; Montecucco F; Rochemont V; Frias MA; Mach F; James RW; Naus CC; Chanson M; Lampe PD; Nielsen MS; Nielsen LB; Kwak BR
    Cardiovasc Res; 2016 Mar; 109(3):385-96. PubMed ID: 26762268
    [TBL] [Abstract][Full Text] [Related]  

  • 6. S1P1-selective agonist SEW2871 exacerbates reperfusion arrhythmias.
    Tsukada YT; Sanna MG; Rosen H; Gottlieb RA
    J Cardiovasc Pharmacol; 2007 Dec; 50(6):660-9. PubMed ID: 18091583
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mapping pathways downstream of sphingosine 1-phosphate subtype 1 by differential chemical perturbation and proteomics.
    Gonzalez-Cabrera PJ; Hla T; Rosen H
    J Biol Chem; 2007 Mar; 282(10):7254-64. PubMed ID: 17218309
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sphingosine 1-phosphate (S1P) receptor agonists mediate pro-fibrotic responses in normal human lung fibroblasts via S1P2 and S1P3 receptors and Smad-independent signaling.
    Sobel K; Menyhart K; Killer N; Renault B; Bauer Y; Studer R; Steiner B; Bolli MH; Nayler O; Gatfield J
    J Biol Chem; 2013 May; 288(21):14839-51. PubMed ID: 23589284
    [TBL] [Abstract][Full Text] [Related]  

  • 9. P2X7 receptor agonists pre- and postcondition the heart against ischemia-reperfusion injury by opening pannexin-1/P2X₇ channels.
    Vessey DA; Li L; Kelley M
    Am J Physiol Heart Circ Physiol; 2011 Sep; 301(3):H881-7. PubMed ID: 21685263
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interplay between SAFE and RISK pathways in sphingosine-1-phosphate-induced cardioprotection.
    Somers SJ; Frias M; Lacerda L; Opie LH; Lecour S
    Cardiovasc Drugs Ther; 2012 Jun; 26(3):227-37. PubMed ID: 22392184
    [TBL] [Abstract][Full Text] [Related]  

  • 11. S1P1-selective in vivo-active agonists from high-throughput screening: off-the-shelf chemical probes of receptor interactions, signaling, and fate.
    Jo E; Sanna MG; Gonzalez-Cabrera PJ; Thangada S; Tigyi G; Osborne DA; Hla T; Parrill AL; Rosen H
    Chem Biol; 2005 Jun; 12(6):703-15. PubMed ID: 15975516
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FTY720 postconditions isolated perfused heart by a mechanism independent of sphingosine kinase 2 and different from S1P or ischemic postconditioning.
    Vessey DA; Li L; Imhof I; Honbo N; Karliner JS
    Med Sci Monit Basic Res; 2013 Apr; 19():126-32. PubMed ID: 23567658
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FTY720 prevents ischemia/reperfusion injury-associated arrhythmias in an ex vivo rat heart model via activation of Pak1/Akt signaling.
    Egom EE; Ke Y; Musa H; Mohamed TM; Wang T; Cartwright E; Solaro RJ; Lei M
    J Mol Cell Cardiol; 2010 Feb; 48(2):406-14. PubMed ID: 19852968
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sphingosine kinase and sphingosine 1-phosphate in cardioprotection.
    Karliner JS
    J Cardiovasc Pharmacol; 2009 Mar; 53(3):189-97. PubMed ID: 19247197
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sphingosin-1-phosphate Receptor 1: a Potential Target to Inhibit Neuroinflammation and Restore the Sphingosin-1-phosphate Metabolism.
    Kolahdooz Z; Nasoohi S; Asle-Rousta M; Ahmadiani A; Dargahi L
    Can J Neurol Sci; 2015 May; 42(3):195-202. PubMed ID: 25860537
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Growth hormone-releasing hormone promotes survival of cardiac myocytes in vitro and protects against ischaemia-reperfusion injury in rat heart.
    Granata R; Trovato L; Gallo MP; Destefanis S; Settanni F; Scarlatti F; Brero A; Ramella R; Volante M; Isgaard J; Levi R; Papotti M; Alloatti G; Ghigo E
    Cardiovasc Res; 2009 Jul; 83(2):303-12. PubMed ID: 19293247
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New players on the center stage: sphingosine 1-phosphate and its receptors as drug targets.
    Huwiler A; Pfeilschifter J
    Biochem Pharmacol; 2008 May; 75(10):1893-900. PubMed ID: 18321471
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FTY720 inhibits S1P-mediated endothelial healing: relationship to S1P1-receptor surface expression.
    Krump-Konvalinkova V; Chwalla I; Siess W
    Biochem Biophys Res Commun; 2008 Jun; 370(4):603-8. PubMed ID: 18402775
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phosphorylated FTY720 promotes astrocyte migration through sphingosine-1-phosphate receptors.
    Mullershausen F; Craveiro LM; Shin Y; Cortes-Cros M; Bassilana F; Osinde M; Wishart WL; Guerini D; Thallmair M; Schwab ME; Sivasankaran R; Seuwen K; Dev KK
    J Neurochem; 2007 Aug; 102(4):1151-61. PubMed ID: 17488279
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanism of sphingosine-1-phosphate induced cardioprotection against I/R injury in diabetic rat heart: Possible involvement of glycogen synthase kinase 3β and mitochondrial permeability transition pore.
    Rana A; Sharma S
    Clin Exp Pharmacol Physiol; 2016 Feb; 43(2):166-73. PubMed ID: 26582369
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.